Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Tjoa

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Immunology Letters|September 21, 2000
Development of dendritic-cell based prostate cancer vaccineB A Tjoa, G P Murphy
Expert Opinion on Investigational Drugs|November 4, 2000
Progress in active-specific immunotherapy of brain malignanciesB A Tjoa, M L Salgaller
Seminars in Surgical Oncology|January 5, 2000
Progress in active specific immunotherapy of prostate cancerB A Tjoa, G P Murphy
Molecular Immunology|July 1, 1994
Sequence restrictions in T cell receptor beta-chains that have specificity for a self-peptide/Ld complexB A Tjoa, D M Kranz
Cancer Research|January 1, 1994
Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejectionB A Tjoa, D M Kranz
The Urologic Clinics of North America|June 11, 1999
Vaccine therapy for prostate cancerB A Tjoa, A A Elgamal, G P Murphy
CA: a Cancer Journal for Clinicians|February 24, 2001
Dendritic cell-based immunotherapy for prostate cancerB A Tjoa, P A Lodge, M L Salgaller, et al.
The Prostate|March 22, 2000
Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patientsG P Murphy, B A Tjoa, S J Simmons, et al.
Critical Reviews in Immunology|January 7, 1998
Dendritic cell-based immunotherapy of prostate cancerM L Salgaller, B A Tjoa, P A Lodge, et al.
Molecular Immunology|December 1, 1992
Sequence diversity of T cell receptor alpha chain transcripts from BALB/c thymusM E Roth, B A Tjoa, C J Schlueter, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Immunology Letters|September 21, 2000
Development of dendritic-cell based prostate cancer vaccineB A Tjoa, G P Murphy
Expert Opinion on Investigational Drugs|November 4, 2000
Progress in active-specific immunotherapy of brain malignanciesB A Tjoa, M L Salgaller
Seminars in Surgical Oncology|January 5, 2000
Progress in active specific immunotherapy of prostate cancerB A Tjoa, G P Murphy
Molecular Immunology|July 1, 1994
Sequence restrictions in T cell receptor beta-chains that have specificity for a self-peptide/Ld complexB A Tjoa, D M Kranz
Cancer Research|January 1, 1994
Generation of cytotoxic T-lymphocytes to a self-peptide/class I complex: a model for peptide-mediated tumor rejectionB A Tjoa, D M Kranz
The Urologic Clinics of North America|June 11, 1999
Vaccine therapy for prostate cancerB A Tjoa, A A Elgamal, G P Murphy
CA: a Cancer Journal for Clinicians|February 24, 2001
Dendritic cell-based immunotherapy for prostate cancerB A Tjoa, P A Lodge, M L Salgaller, et al.
The Prostate|March 22, 2000
Higher-dose and less frequent dendritic cell infusions with PSMA peptides in hormone-refractory metastatic prostate cancer patientsG P Murphy, B A Tjoa, S J Simmons, et al.
Critical Reviews in Immunology|January 7, 1998
Dendritic cell-based immunotherapy of prostate cancerM L Salgaller, B A Tjoa, P A Lodge, et al.
Molecular Immunology|December 1, 1992
Sequence diversity of T cell receptor alpha chain transcripts from BALB/c thymusM E Roth, B A Tjoa, C J Schlueter, et al.
Pageof 2